IP Library Granted Patent US 7,022,890
Granted Patent B2
US 7,022,890 · App. 10/946,687 · Granted Apr 4, 2006

Wound dressing suitable for insertion in nasal passages

Assignee: Ferris Pharmaceuticals
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,022,890
App. No.
10/946,687
Granted
Apr 4, 2006
Kind
B2
Abstract

The invention provides a wound dressing comprising a body and a polymeric film adhered to at least a portion of the body. The body comprises a flexible, porous polyurethane-based foam and a liquid absorbing component. The invention further provides a wound dressing comprising a first body, a second body, and at least one polymeric film disposed between the first and second bodies. The invention additionally provides methods for treating an injury to a patient's nasal passages utilizing a wound dressing according to the invention.

Claims (50)

1. A wound dressing having an exterior portion adapted to contact a wound comprising:

(i) a first body comprising a flexible, porous polyurethane-based foam and a liquid absorbing component,

(ii) a second body comprising a flexible, porous polyurethane-based foam and a liquid absorbing component, and

(iii) at least one polymeric film intermediate of at least a portion of a surface of the first body and at least a portion of a surface of the second body.

wherein the first and second bodies are adhered to each other so that at least a portion of the polymeric film is disposed between the first and second bodies, and

wherein at least a portion of the exterior of the first and second bodies comprise the exterior portion of the wound dressing and are capable of absorbing liquid.

2. The wound dressing of claim 1 , wherein the liquid absorbing components comprise a superabsorbent polymer.

3. The wound dressing of claim 2 , wherein the first and second bodies further comprise an adjuvant dispersed in the foam.

4. The wound dressing of claim 3 , wherein the adjuvant comprises glycerin.

5. The wound dressing of claim 4 , wherein the first and second bodies further comprise a surfactant dispersed in the foam.

6. The wound dressing of claim 1 , wherein the first and second bodies further comprise an adjuvant dispersed in the foam.

7. The wound dressing of claim 6 , wherein the adjuvant comprises glycerin.

8. The wound dressing of claim 1 , wherein the first and second bodies further comprise a surfactant dispersed in the foam.

9. The wound dressing of claim 1 , wherein the dressing further comprises a tether attached to the dressing and extending from one end of the dressing to assist in stabilization of the dressing within a body cavity or removal of the dressing from a body cavity.

10. A method for treating an injury to a nasal passage, the method comprising the steps of:

(a) providing a wound dressing having an exterior portion adapted to contact a wound comprising:

(i) a first body comprising a flexible, porous polyurethane-based foam and a liquid absorbing component,

(ii) a second body comprising a flexible, porous polyurethane-based foam and a liquid absorbing component, and

(iii) a polymeric film intermediate of at least a portion of a surface of the first body and at least a portion of a surface of the second body, wherein at least a portion of the exterior of the first and second bodies comprise the exterior portion of the wound dressing and are capable of absorbing liquid,

(b) inserting the wound dressing into a patient's nasal passage so that at least a portion of the exterior portion of the wound dressing contacts an injured surface of the nasal passage.

(c) retaining the wound dressing in the patient's nasal passage for a time sufficient for the injury to at least partially heal, and

(d) removing the wound dressing from the patient's nasal passage.

11. The method of claim 10 , wherein the liquid absorbing component comprises a superabsorbent polymer.

12. The method of claim 10 , wherein the wound dressing further comprises a reinforcing film adhered to at least a portion of a surface of the body.

13. The method of claim 10 , wherein the body of the dressing is provided in a substantially cylindrical, conical, or frustro-conical shape.

14. The method of claim 10 , wherein the wound dressing is folded along its longest dimension prior to insertion into the patient's nasal passage.

15. The method of claim 14 , wherein the wound dressing is folded so that the polymeric film is disposed between the two folded halves of the wound dressing.

16. The method of claim 10 , wherein the wound dressing is rolled or twisted prior to insertion into a patient's nasal passage.

17. A method for treating an injury to a nasal passage, the method comprising the steps of:

(a) providing a wound dressing comprising:

(i) a first body comprising a flexible, porous polyurethane-based foam and a liquid absorbing component,

(ii) a second body comprising a flexible, porous polyurethane-based foam and a liquid absorbing component, and

(iii) at least one polymeric film adhered to at least a portion of a surface of the first or second body,

wherein the first and second bodies are adhered to each other so that at least a portion of the polymeric film is disposed between the first and second bodies,

(b) inserting the wound dressing into a patient's nasal passage so that at least a portion of the wound dressing contacts an injured surface of the nasal passage,

(c) retaining the wound dressing in the patient's nasal passage for a time sufficient for the injury to at least partially heal, and

(d) removing the wound dressing from the patient's nasal passage.

18. The method of claim 17 , wherein the liquid absorbing components comprise a superabsorbent polymer.

19. The method of claim 17 , wherein the first and second bodies are provided in a substantially cylindrical, conical, or frustro-conical shape.

20. The method of claim 17 , wherein the wound dressing is folded prior to insertion into the patient's nasal passage.

21. The method of claim 17 , wherein the wound dressing comprises an external portion, and wherein at least a portion of the exterior portion of the wound dressing contacts the injured surface of the nasal passage during step (c).

22. The method of claim 21 , wherein the liquid absorbing components comprise a superabsorbent polymer.

23. The method of claim 22 , wherein the first and second bodies further comprise an adjuvant dispersed in the foam.

24. The method of claim 23 , wherein the adjuvant comprises glycerin.

25. The method of claim 23 , wherein the first and second bodies further comprise a surfactant dispersed in the foam.

26. The method of claim 17 , wherein the dressing further comprises a tether attached to the dressing and extending from one end of the dressing to assist in stabilization of the dressing within a body cavity or removal.

27. The method of claim 17 , wherein the wound dressing is folded along its longest dimension prior to insertion into the nasal passage.

28. The method of claim 17 , wherein the wound dressing is folded so that the polymeric film is disposed between the two folded halves of the wound dressing.

29. The method of claim 17 , wherein the wound dressing is rolled or twisted prior to insertion into the nasal passage.

30. The method of claim 17 , wherein the polymeric film is semipermeable.

Assignments (2)
CHANGE OF NAME Recorded Dec 23, 2009
From: FERRIS PHARMACEUTICALS INC.
To: SESSIONS PHARMACEUTICALS INC.
Reel/Frame 023699/0129 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2005
From: SESSIONS, ROBERT W.
To: FERRIS PHARMACEUTICALS INC.
Reel/Frame 015549/0911 →
Continuity (2)
Provisional Application 6050484300 · Sep 22, 2003
Related Publication 20050107731A1 · May 19, 2005